IL124881A0 - Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer - Google Patents
Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancerInfo
- Publication number
- IL124881A0 IL124881A0 IL12488197A IL12488197A IL124881A0 IL 124881 A0 IL124881 A0 IL 124881A0 IL 12488197 A IL12488197 A IL 12488197A IL 12488197 A IL12488197 A IL 12488197A IL 124881 A0 IL124881 A0 IL 124881A0
- Authority
- IL
- Israel
- Prior art keywords
- centchroman
- enantiomer
- prophylaxis
- manufacture
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1000096P | 1996-01-11 | 1996-01-11 | |
| DK77696 | 1996-07-11 | ||
| PCT/DK1997/000007 WO1997025034A1 (en) | 1996-01-11 | 1997-01-09 | Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL124881A0 true IL124881A0 (en) | 1999-01-26 |
Family
ID=26064631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12488197A IL124881A0 (en) | 1996-01-11 | 1997-01-09 | Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0873119A1 (xx) |
| JP (1) | JP2001500101A (xx) |
| KR (1) | KR19990077157A (xx) |
| AU (1) | AU1367197A (xx) |
| BR (1) | BR9706966A (xx) |
| CA (1) | CA2241462A1 (xx) |
| CZ (1) | CZ217198A3 (xx) |
| HU (1) | HUP9901633A3 (xx) |
| IL (1) | IL124881A0 (xx) |
| NO (1) | NO983177L (xx) |
| PL (1) | PL328135A1 (xx) |
| WO (1) | WO1997025034A1 (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1028724A1 (en) * | 1997-11-10 | 2000-08-23 | Novo Nordisk A/S | Transdermal delivery of 3,4-diarylchromans |
| US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| AU2004200099B2 (en) * | 1998-06-11 | 2006-11-02 | Endorecherche, Inc. | Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| AU2011253842B2 (en) * | 1998-06-11 | 2014-08-14 | Endorecherche Inc. | Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors |
| CN106038572A (zh) | 2004-10-20 | 2016-10-26 | 恩多研究公司 | 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍 |
| US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
| CA2702710C (en) | 2007-10-16 | 2013-05-07 | Repros Therapeutics, Inc. | Trans-clomiphene for metabolic syndrome |
| US20100317635A1 (en) | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
| WO2011156908A1 (en) | 2010-06-16 | 2011-12-22 | Endorecherche, Inc. | Methods of treating or preventing estrogen-related diseases |
| ES2681023T3 (es) | 2012-02-29 | 2018-09-11 | Repros Therapeutics Inc. | Terapia de combinación para tratar el déficit de andrógenos |
| US9744177B2 (en) | 2014-03-10 | 2017-08-29 | Endorecherche, Inc. | Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM |
| CN108348605B (zh) | 2015-11-10 | 2023-06-09 | 帕拉卡林治疗公司 | 用pdgf-cc抑制剂和抗雌激素治疗er阴性乳癌 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447622A (en) * | 1981-09-22 | 1984-05-08 | Council Of Scientific And Industrial Research Rafi Marg | Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof |
-
1997
- 1997-01-09 WO PCT/DK1997/000007 patent/WO1997025034A1/en not_active Application Discontinuation
- 1997-01-09 JP JP09524767A patent/JP2001500101A/ja active Pending
- 1997-01-09 HU HU9901633A patent/HUP9901633A3/hu unknown
- 1997-01-09 CZ CZ982171A patent/CZ217198A3/cs unknown
- 1997-01-09 CA CA002241462A patent/CA2241462A1/en not_active Abandoned
- 1997-01-09 PL PL97328135A patent/PL328135A1/xx unknown
- 1997-01-09 AU AU13671/97A patent/AU1367197A/en not_active Abandoned
- 1997-01-09 EP EP97900199A patent/EP0873119A1/en not_active Withdrawn
- 1997-01-09 BR BR9706966A patent/BR9706966A/pt not_active Application Discontinuation
- 1997-01-09 IL IL12488197A patent/IL124881A0/xx unknown
- 1997-01-09 KR KR1019980705295A patent/KR19990077157A/ko not_active Application Discontinuation
-
1998
- 1998-07-10 NO NO983177A patent/NO983177L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990077157A (ko) | 1999-10-25 |
| NO983177L (no) | 1998-07-10 |
| AU1367197A (en) | 1997-08-01 |
| CA2241462A1 (en) | 1997-07-17 |
| BR9706966A (pt) | 1999-05-04 |
| HUP9901633A2 (hu) | 1999-10-28 |
| WO1997025034A1 (en) | 1997-07-17 |
| CZ217198A3 (cs) | 1998-11-11 |
| PL328135A1 (en) | 1999-01-18 |
| JP2001500101A (ja) | 2001-01-09 |
| EP0873119A1 (en) | 1998-10-28 |
| HUP9901633A3 (en) | 2000-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112969A0 (en) | Pharmaceutical composition comprising t-cell actiVator for the treatment of cancer | |
| AP9700939A0 (en) | Compounds and methods for the treatment of cancer | |
| ZA96740B (en) | Skin treatment composition | |
| EP0942742A4 (en) | THERAPEUTIC COMPOSITIONS FOR CANCER TREATMENT | |
| AU1980995A (en) | Methods and compositions for treatment of breast cancer | |
| ZA953256B (en) | Skin treatment composition | |
| HUP9903166A3 (en) | Medicinal compositions for the prophylaxis or treatment of arteriosclerosis | |
| ZA982968B (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| IL124881A0 (en) | Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
| HUP9802861A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
| AU5005197A (en) | Prophylaxis of breast cancer | |
| IL121329A0 (en) | A pharmaceutical composition for the treatment of cancer | |
| GB9405021D0 (en) | Skin treatment composition | |
| GB9510162D0 (en) | Compositions for the treatment of skin conditions | |
| ZA922073B (en) | New compounds for use in the treatment of cancer | |
| EP0918788A4 (en) | BRCA1 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING BREAST CANCER | |
| ZA97215B (en) | Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
| EP0755262A4 (en) | PNEUMOPATHY TREATMENT COMPOSITION | |
| GB9405046D0 (en) | Skin treatment composition | |
| GB2312375B (en) | Agents for treatment of cancer | |
| HU9700079D0 (en) | Topical compositions for the treatment of skin disease | |
| ZA979720B (en) | Prophylaxis of breast cancer | |
| EP0460690A3 (en) | Use of phenolsulfophthaline derivatives for the treatment of osteoporosis | |
| EP0810866A4 (en) | USE IN THE TREATMENT OF CANCERS OF ORGANOMETALLIC COMPOUNDS OF ACID-SENSITIVE TRANSITION METALS | |
| IL123422A (en) | USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS |